Abstract
Background
Local recurrence is the most difficult postoperative challenge and the leading cause of death in patients with retroperitoneal liposarcoma (RLPS). We aimed to establish a postoperative nomogram exclusively focused on RLPS for predicting local recurrence-free survival (LRFS).
Methods
A cohort of 124 patients after surgical resection with curative intent in the Peking University Cancer Hospital Sarcoma Center were included in the study. Demographic, clinicopathologic, and treatment variables were analyzed using the Cox regression model. Significant clinically relevant variables in multivariable analysis were incorporated into the RLPS-specific nomogram. The discriminative ability and predictive accuracy of the nomogram were assessed by calculating the concordance index and drawing a calibration plot.
Results
At a median follow-up of 26.5 (interquartile range 10.9–39.4) months, 71 patients had recurrent disease. The 3-year and 5-year LRFS rates were 35.6% (95% confidence interval, 27.0–46.9%) and 28.2% (95% CI 15.8–38.6%), respectively. Multivariate analysis identified the French Federation of Cancer Centers Sarcoma Group (FNCLCC) grade and completeness of resection as independent predictors of LRFS. Variables included in our nomogram were: presentation status, multifocality, completeness of resection, histologic subtypes, and FNCLCC grade. The concordance index of our nomogram was 0.732 (95% CI 0.667–0.797) and the calibration plot was excellent.
Conclusions
Our novel nomogram for patients with resected RLPS could improve recurrence risk stratification to explore molecular analysis associated with recurrence.
Similar content being viewed by others
References
Dei Tos AP (2000) Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol 4(4):252–266. https://doi.org/10.1053/adpa.2000.8133
Vijay A, Ram L (2015) Retroperitoneal liposarcoma: a comprehensive review. Am J Clin Oncol 38(2):213–219. https://doi.org/10.1097/COC.0b013e31829b5667
Haas RLM, Bonvalot S, Miceli R et al (2019) Radiotherapy for retroperitoneal liposarcoma: a report from the Transatlantic Retroperitoneal Sarcoma Working Group. Cancer 125(8):1290–1300. https://doi.org/10.1002/cncr.31927
Lee ATJ, Thway K, Huang PH et al (2018) Clinical and molecular spectrum of liposarcoma. J Clin Oncol 36(2):151–159. https://doi.org/10.1200/JCO.2017.74.9598
Bagaria SP, Gabriel E, Mann GN (2018) Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol 117(1):62–68. https://doi.org/10.1002/jso.24929
Park JO, Qin L-X, Prete FP et al (2009) Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg 250(6):977–982. https://doi.org/10.1097/sla.0b013e3181b2468b
Hamilton TD, Cannell AJ, Kim M et al (2017) Results of resection for recurrent or residual retroperitoneal sarcoma after failed primary treatment. Ann Surg Oncol 24(1):211–218. https://doi.org/10.1245/s10434-016-5523-6
Abdelfatah E, Guzzetta AA, Nagarajan N et al (2016) Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol 114(1):56–64. https://doi.org/10.1002/jso.24256
Gronchi A, Strauss DC, Miceli R et al (2016) Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative rps working group. Ann Surg 263(5):1002–1009. https://doi.org/10.1097/SLA.0000000000001447
Singer S, Antonescu CR, Riedel E et al (2003) Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. https://doi.org/10.1097/01.sla.0000086542.11899.38
Bartlett EK, Curtin CE, Seier K et al (2019) Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma. Ann Surg. https://doi.org/10.1097/SLA.0000000000003453
Jo VY, Fletcher CDM (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. https://doi.org/10.1097/pat.0000000000000050
Anaya DA, Lahat G, Liu J et al (2009) Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137–142. https://doi.org/10.1097/SLA.0b013e3181928f2f
Fairweather M, Wang J, Jo VY et al (2018) Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol. https://doi.org/10.1245/s10434-017-6136-4
Grobmyer SR, Wilson JP, Apel B et al (2010) Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes. J Am Coll Surg. https://doi.org/10.1016/j.jamcollsurg.2009.12.024
Tan MCB, Brennan MF, Kuk D et al (2016) Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 263(3):593–600. https://doi.org/10.1097/SLA.0000000000001149
Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https://doi.org/10.1136/bmj.g7594
Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364–1370. https://doi.org/10.1200/JCO.2007.12.9791
Callegaro D, Miceli R, Mariani L et al (2017) Soft tissue sarcoma nomograms and their incorporation into practice. Cancer 123(15):2802–2820. https://doi.org/10.1002/cncr.30721
Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14(5):1679–1689. https://doi.org/10.1200/JCO.1996.14.5.1679
Anaya DA, Lahat G, Wang X et al (2010) Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397–402. https://doi.org/10.1093/annonc/mdp298
Ardoino I, Miceli R, Berselli M et al (2010) Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer 116(10):2429–2436. https://doi.org/10.1002/cncr.25057
Dalal KM, Kattan MW, Antonescu CR et al (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244(3):381–391. https://doi.org/10.1097/01.sla.0000234795.98607.00
Lahat G, Tuvin D, Wei C et al (2008) New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 15(10):2739–2748. https://doi.org/10.1245/s10434-008-9970-6
Nathan H, Raut CP, Thornton K et al (2009) Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 250(6):970–976. https://doi.org/10.1097/SLA.0b013e3181b25183
Gronchi A, Miceli R, Shurell E et al (2013) Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 31(13):1649–1655. https://doi.org/10.1200/JCO.2012.44.3747
Raut CP, Callegaro D, Miceli R et al (2019) Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res 25(8):2664–2671. https://doi.org/10.1158/1078-0432.CCR-18-2700
Cananzi FCM, Ruspi L, Sicoli F et al (2019) Did outcomes improve in retroperitoneal sarcoma surgery? Surg Oncol. https://doi.org/10.1016/j.suronc.2018.11.004
Tseng WW, Madewell JE, Wei W et al (2014) Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol 21(7):2136–2143. https://doi.org/10.1245/s10434-014-3643-4
Jensen OM, Høgh J, Ostgaard SE et al (1991) Histopathological grading of soft tissue tumours prognostic significance in a prospective study of 278 consecutive cases. J Pathol 163(1):19–24. https://doi.org/10.1002/path.1711630105
Neuhaus SJ, Barry P, Clark MA et al (2005) Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg 92(2):246–252. https://doi.org/10.1002/bjs.4802
Linehan DC, Lewis JJ, Leung D et al (2000) Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol 18(8):1637–1643. https://doi.org/10.1200/JCO.2000.18.8.1637
Gronchi A, Miceli R, Allard MA et al (2015) Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol 22(5):1447–1454. https://doi.org/10.1245/s10434-014-4130-7
Bonvalot S, Rivoire M, Castaing M et al (2009) Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(1):31–37. https://doi.org/10.1200/JCO.2008.18.0802
Gyorki DE, Brennan MF (2014) Management of recurrent retroperitoneal sarcoma. J Surg Oncol 109(1):53–59. https://doi.org/10.1002/jso.23463
Acknowledgements
This work was supported by the Capital Health Research and Development of Special Funds (Grant Number: 2020-1-1021); the Beijing Municipal Administration of Hospitals’ Ascent Plan (Grant Number: DFL20181104); and Beijing Municipal Administration of Hospitals’ Youth Program (Grant Number: QML20181104).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
The study was approved by the ethics committee of the Peking University Cancer Hospital. Patients provided written informed consent for data collection.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Xue, G., Wang, Z., Li, C. et al. A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center. Int J Clin Oncol 26, 145–153 (2021). https://doi.org/10.1007/s10147-020-01796-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-020-01796-6